Addex Therapeutics Ltd (SWX: ADXN)
Switzerland
· Delayed Price · Currency is CHF
0.0672
-0.0004 (-0.59%)
Oct 1, 2024, 5:30 PM CET
Addex Therapeutics Revenue
Addex Therapeutics had revenue of 115.28K CHF in the quarter ending June 30, 2024, a decrease of -81.76%. This brings the company's revenue in the last twelve months to 863.23K, down -59.82% year-over-year. In the year 2023, Addex Therapeutics had annual revenue of 1.65M with 13.99% growth.
Revenue (ttm)
863.23K
Revenue Growth
-59.82%
P/S Ratio
7.29
Revenue / Employee
37.53K
Employees
23
Market Cap
6.88M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.65M | 202.11K | 13.99% |
Dec 31, 2022 | 1.44M | -1.71M | -54.18% |
Dec 31, 2021 | 3.15M | -725.84K | -18.71% |
Dec 31, 2020 | 3.88M | 1.05M | 36.89% |
Dec 31, 2019 | 2.83M | -3.87M | -57.72% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 60.58B |
Roche Holding AG | 60.58B |
Novartis AG | 43.91B |
Lonza Group AG | 6.70B |
Straumann Holding AG | 2.54B |
Galderma Group AG | 3.88B |
Sonova Holding AG | 3.63B |
Ypsomed Holding AG | 548.46M |
Addex Therapeutics News
- 19 days ago - Addex Therapeutics reports H1 results - Seeking Alpha
- 19 days ago - Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit - GlobeNewsWire
- 4 weeks ago - Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 5 weeks ago - S&P 500 Edges Higher; American Woodmark Shares Slide - Benzinga
- 6 weeks ago - Crude Oil Dips; Addex Therapeutics Shares Spike Higher - Benzinga
- 6 weeks ago - Crude Oil Dips; Addex Therapeutics Shares Spike Higher - Benzinga
- 6 weeks ago - Why Addex Therapeutics stock skyrocketed 70% on Tuesday - Invezz
- 6 weeks ago - Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder - Benzinga